BiotechTube
Home/BrePco Biopharma/Paul Breen
PB

Paul Breen

Founder and Director

BrePco Biopharma

Therapeutic Areas

Pediatric Critical CareCardiovascular

BrePco Biopharma Pipeline

DrugIndicationPhase
Neoatricon® (dopamine hydrochloride)Hypotension in haemodynamically unstable neonates, infants, and children under 18Approved

Leadership Team at BrePco Biopharma

SO
Seamus O'Loan
Director
JQ
Jenny Quinn
Manager of Quality and Compliance
View full BrePco Biopharma profile